Coronary artery disease risk reclassification using an acoustic-based score in view of the new European Society of Cardiology 2019 guidelines on Chronic Coronary Syndromes by Schmidt, S. E. et al.
 
  
 
Aalborg Universitet
Coronary artery disease risk reclassification using an acoustic-based score in view of
the new European Society of Cardiology 2019 guidelines on Chronic Coronary
Syndromes
Schmidt, S. E.; Winther, S.; Boettcher, M.
Published in:
International Journal of Cardiovascular Imaging
DOI (link to publication from Publisher):
10.1007/s10554-019-01746-y
Creative Commons License
CC BY 4.0
Publication date:
2020
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Schmidt, S. E., Winther, S., & Boettcher, M. (2020). Coronary artery disease risk reclassification using an
acoustic-based score in view of the new European Society of Cardiology 2019 guidelines on Chronic Coronary
Syndromes. International Journal of Cardiovascular Imaging, 36(3), 383-384. https://doi.org/10.1007/s10554-
019-01746-y
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Vol.:(0123456789) 
The International Journal of Cardiovascular Imaging (2020) 36:383–384 
https://doi.org/10.1007/s10554-019-01746-y
ORIGINAL PAPER
Coronary artery disease risk reclassification using an acoustic‑based 
score in view of the new European Society of Cardiology 2019 
guidelines on Chronic Coronary Syndromes
S. E. Schmidt1  · S. Winther2 · M. Boettcher2
Received: 5 December 2019 / Accepted: 9 December 2019 / Published online: 18 December 2019 
© The Author(s) 2019
Abstract
In August 2019, ESC published new guidelines on Chronic Coronary Syndromes including a new risk assessment paradigm 
for estimation of pre-test-probability. The CAD-score is an acoustic-based score for ruling-out of coronary artery disease 
(CAD). In the current letter to the editor we re-evaluate the re-classification potential the CAD-score in the view of the new 
guidelines.
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Introduction
In July 2019 the International Journal of Cardiovascular 
Imaging published our study about coronary artery disease 
(CAD) risk reclassification using an acoustic-based score 
[1]. A key point in the publication is the capability of the 
CAD-score to reclassify patient from their original pre-test-
probability (PTP) to a lower risk class according to the 2013 
European Society of Cardiology (ESC) guidelines on the 
management of stable CAD. In August 2019, ESC published 
their new guidelines on Chronic Coronary Syndromes [2]. 
Key changes in the 2019 guidelines related to estimation of 
PTP were that the threshold defining low risk was lowered 
from 15 to 5%, and the introduction of a new PTP score 
with PTP values considerably lower than the previously rec-
ommended score. In addition, the new score now includes 
dyspnea as a symptom. In the current letter to the editor we 
have recalculated the CAD-score reclassification outcome 
according to the new ESC 2019 guidelines.
Methods
PTP was calculated for all patients referred with suspected 
CAD [1] using the new PTP table from the ESC 2019 guide-
lines. Patients with a PTP equal to or below 5% were classi-
fied as low likelihood. We reclassified patients with a PTP 
above 5% into the low likelihood group if their CAD-score 
was less or equal to 20. For two subjects, the new PTP score 
could not be calculated as they were below 30 years of age.
Results
The mean PTP estimated from the ECS 2019 guidelines was 
16.2% (SD: 11.5%) in the 1671 patients referred for testing 
due to suspected CAD. 178 (10.7%) had low likelihood of 
CAD (≤ 5%). Post CAD-score test this number increased to 
679 (40.6%) (Fig. 2). Before testing, 6 (3.4%) patients with 
low PTP had significant-CAD, whereas post-reclassification 
this number increased to 28 (4.1%) (p = 0.52). If the PTP 
was not taken into consideration and all patients were clas-
sified only according to whenever their CAD-score was less 
or equal to 20, 631 patients (37.8%) were classified as low 
likelihood and 24 had significant-CAD (3.8%). * S. E. Schmidt 
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Discussion
In this low prevalence population, the new PTP score from 
the ESC 2019 guidelines classified 10.7% of patients as low 
likelihood. Thereby, to avoid unnecessary testing, the need 
for reclassifying the remaining nearly 90% of patients, where 
the majority is not having CAD but non-invasive testing is 
recommended, is still evident. As in the original study, 4 
out of 10 patients becomes classified as low risk after appli-
cation of the CAD-score scheme. This reclassification did 
not increase the prevalence of CAD-subjects in the low risk 
group above the 5% limit recommended in the ESC 2019 
guidelines (from 3.4 to 4.1%). Therefore, the relevance and 
effectives of the CAD-score as a potential rule-out device 
persists after application of the new ESC 2019 guidelines 
on Chronic Coronary Syndromes.
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